1339 related articles for article (PubMed ID: 33029768)
1. An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner.
Agrawal H; Das N; Nathani S; Saha S; Saini S; Kakar SS; Roy P
Stem Cell Rev Rep; 2021 Feb; 17(1):94-112. PubMed ID: 33029768
[TBL] [Abstract][Full Text] [Related]
2. Physiological Relevance of Angiotensin Converting Enzyme 2 As a Metabolic Linker and Therapeutic Implication of Mesenchymal Stem Cells in COVID-19 and Hypertension.
Saha S; Chakrabarti S; Singh PK; Poddar J; Satapathi S; Saini S; Kakar SS; Roy P
Stem Cell Rev Rep; 2021 Feb; 17(1):132-143. PubMed ID: 32748331
[TBL] [Abstract][Full Text] [Related]
3. The Renin-Angiotensin System: A Key Role in SARS-CoV-2-Induced COVID-19.
El-Arif G; Farhat A; Khazaal S; Annweiler C; Kovacic H; Wu Y; Cao Z; Fajloun Z; Khattar ZA; Sabatier JM
Molecules; 2021 Nov; 26(22):. PubMed ID: 34834033
[TBL] [Abstract][Full Text] [Related]
4. Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones.
Viveiros A; Rasmuson J; Vu J; Mulvagh SL; Yip CYY; Norris CM; Oudit GY
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H296-H304. PubMed ID: 33275517
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45
Ratajczak MZ; Bujko K; Ciechanowicz A; Sielatycka K; Cymer M; Marlicz W; Kucia M
Stem Cell Rev Rep; 2021 Feb; 17(1):266-277. PubMed ID: 32691370
[TBL] [Abstract][Full Text] [Related]
6. The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure.
Angeli F; Zappa M; Reboldi G; Gentile G; Trapasso M; Spanevello A; Verdecchia P
Eur J Intern Med; 2023 Mar; 109():12-21. PubMed ID: 36528504
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and cardiovascular diseases.
Liu F; Liu F; Wang L
J Mol Cell Biol; 2021 Jul; 13(3):161-167. PubMed ID: 33226078
[TBL] [Abstract][Full Text] [Related]
8. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation.
Augustine R; S A; Nayeem A; Salam SA; Augustine P; Dan P; Maureira P; Mraiche F; Gentile C; Hansbro PM; McClements L; Hasan A
Chem Biol Interact; 2022 Jan; 351():109738. PubMed ID: 34740598
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities.
Nashiry A; Sarmin Sumi S; Islam S; Quinn JMW; Moni MA
Brief Bioinform; 2021 Mar; 22(2):1387-1401. PubMed ID: 33458761
[TBL] [Abstract][Full Text] [Related]
10. ACE2: from protection of liver disease to propagation of COVID-19.
Warner FJ; Rajapaksha H; Shackel N; Herath CB
Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
[TBL] [Abstract][Full Text] [Related]
11. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.
Sharma RK; Stevens BR; Obukhov AG; Grant MB; Oudit GY; Li Q; Richards EM; Pepine CJ; Raizada MK
Hypertension; 2020 Sep; 76(3):651-661. PubMed ID: 32783758
[TBL] [Abstract][Full Text] [Related]
12. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
13. Impact of I/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients.
Verma S; Abbas M; Verma S; Khan FH; Raza ST; Siddiqi Z; Ahmad I; Mahdi F
Infect Genet Evol; 2021 Jul; 91():104801. PubMed ID: 33676010
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
Kuba K; Yamaguchi T; Penninger JM
Front Immunol; 2021; 12():732690. PubMed ID: 35003058
[TBL] [Abstract][Full Text] [Related]
15. Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19.
Gemmati D; Tisato V
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899439
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases.
Sharma RK; Li J; Krishnan S; Richards EM; Raizada MK; Mohandas R
Clin Sci (Lond); 2021 Jan; 135(1):1-17. PubMed ID: 33399851
[TBL] [Abstract][Full Text] [Related]
17. Putative mechanism of neurological damage in COVID-19 infection.
Bandala C; Cortes-Altamirano JL; Reyes-Long S; Lara-Padilla E; Ilizaliturri-Flores I; Alfaro-RodrÃguez A
Acta Neurobiol Exp (Wars); 2021; 81(1):69-79. PubMed ID: 33949163
[TBL] [Abstract][Full Text] [Related]
18. Platelets and renal failure in the SARS-CoV-2 syndrome.
Taha M; Sano D; Hanoudi S; Esber Z; Elahi M; Gabali A; Chopra T; Draghici S; Samavati L
Platelets; 2021 Jan; 32(1):130-137. PubMed ID: 32892687
[TBL] [Abstract][Full Text] [Related]
19. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
[TBL] [Abstract][Full Text] [Related]
20. A pressor dose of angiotensin II has no influence on the angiotensin-converting enzyme 2 and other molecules associated with SARS-CoV-2 infection in mice.
Wang Y; Takeshita H; Yamamoto K; Huang Y; Wang C; Nakajima T; Nozato Y; Fujimoto T; Yokoyama S; Hongyo K; Nakagami F; Akasaka H; Takami Y; Takeya Y; Sugimoto K; Rakugi H
FASEB J; 2021 Mar; 35(3):e21419. PubMed ID: 33566370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]